A detailed history of Marshall Wace, LLP transactions in Amgen Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 705,111 shares of AMGN stock, worth $186 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
705,111
Previous 656,498 7.4%
Holding current value
$186 Million
Previous $205 Million 10.76%
% of portfolio
0.29%
Previous 0.28%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $15 Million - $16.4 Million
48,613 Added 7.4%
705,111 $227 Million
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $45.5 Million - $55.3 Million
173,058 Added 35.8%
656,498 $205 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $93.1 Million - $112 Million
346,399 Added 252.77%
483,440 $137 Million
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $361 Million - $407 Million
-1,411,187 Reduced 91.15%
137,041 $39.5 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $291 Million - $362 Million
1,332,231 Added 616.78%
1,548,228 $416 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $15.5 Million - $18.3 Million
72,266 Added 50.28%
215,997 $48 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $19.1 Million - $23.2 Million
84,380 Added 142.17%
143,731 $34.7 Million
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $4.63 Million - $5.88 Million
-20,213 Reduced 25.4%
59,351 $15.6 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $40.1 Million - $45.2 Million
-178,664 Reduced 69.19%
79,564 $17.9 Million
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $14.2 Million - $15.8 Million
-61,702 Reduced 19.29%
258,228 $62.8 Million
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $47.1 Million - $52.2 Million
215,015 Added 204.94%
319,930 $77.4 Million
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $20.3 Million - $23.2 Million
102,066 Added 3582.52%
104,915 $23.6 Million
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $8.5 Million - $9.95 Million
-40,020 Reduced 93.35%
2,849 $606,000
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $4.57 Million - $5.07 Million
-19,556 Reduced 31.33%
42,869 $10.4 Million
Q1 2021

May 17, 2021

BUY
$221.91 - $258.6 $11.3 Million - $13.2 Million
51,049 Added 448.74%
62,425 $15.5 Million
Q4 2020

Feb 16, 2021

BUY
$216.38 - $257.67 $1.23 Million - $1.47 Million
5,686 Added 99.93%
11,376 $2.62 Million
Q3 2020

Nov 16, 2020

SELL
$234.65 - $260.95 $15.5 Million - $17.2 Million
-65,905 Reduced 92.05%
5,690 $1.45 Million
Q2 2020

Aug 13, 2020

BUY
$197.81 - $242.74 $13.2 Million - $16.2 Million
66,642 Added 1345.49%
71,595 $16.9 Million
Q1 2020

May 15, 2020

BUY
$182.24 - $241.7 $902,634 - $1.2 Million
4,953 New
4,953 $1 Million
Q4 2019

Feb 14, 2020

SELL
$189.21 - $243.2 $136,798 - $175,833
-723 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $4.39 Million - $5.26 Million
-25,201 Reduced 97.21%
723 $140,000
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $4.32 Million - $5.07 Million
25,924 New
25,924 $4.78 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.